T. Rowe Price US Large-Cap Core I RCLIX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 43.30  /  +0.58 %
  • Total Assets 19.4 Bil
  • Adj. Expense Ratio
    0.580%
  • Expense Ratio 0.580%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 500,000
  • Status Open
  • TTM Yield 0.40%
  • Turnover 57%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis RCLIX

Will RCLIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

On the right path.

Senior Analyst Stephen Welch

Stephen Welch

Senior Analyst

Summary

Increased confidence in T. Rowe Price U.S. Large-Cap Core’s leader and solid supporting cast earns a People rating upgrade to Above Average from Average.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RCLIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 38.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apple Inc

7.31 1.4 Bil
Technology

NVIDIA Corp

6.84 1.3 Bil
Technology

Microsoft Corp

6.34 1.2 Bil
Technology

Alphabet Inc Class C

4.06 792.4 Mil
Communication Services

Amazon.com Inc

3.80 741.3 Mil
Consumer Cyclical

Visa Inc Class A

2.59 505.6 Mil
Financial Services

UnitedHealth Group Inc

2.23 434.5 Mil
Healthcare

Thermo Fisher Scientific Inc

2.05 400.9 Mil
Healthcare

JPMorgan Chase & Co

1.90 370.9 Mil
Financial Services

Eli Lilly and Co

1.63 317.6 Mil
Healthcare

Sponsor Center